Hospitalisation for heart failure: potassium disturbances common

Lowering mineralocorticoid antagonists associated with higher mortality, say researchers
Reuters Health Staff writer

Inpatient therapy for heart failure can lead to serum potassium disturbances, which appear not to be harmful — but related changes in medication might be, researchers say.

Dutch-led researchers studied data on close to 1600 hospitalised heart-failure patients taking part in a clinical trial. Daily measurements of serum potassium were made from baseline until discharge or day 7 of hospitalisation.

Overall serum potassium concentrations increased significantly, from 4.3mmol/L at baseline to 4.5mmol/L at discharge or day 7. Incident hypokalemia was seen in 17% and incident hyperkalemia in 35% of patients.

Thirty-four patients (2%) had episodes of both hypo- and hyperkalemia.